Miguel Ángel Cuesta-Geijo received his M.Sc. in Microbiology and obtained his Ph.D. in Virology in 2013 from the Autónoma University of Madrid (Spain). He began his Ph.D. in 2008, studying the involvement of the endocitic pathway in African Swine Fever Virus infection. In 2011, he was awarded an international fellowship as part of his Ph.D. student training in the Cell Biology Division at The Netherlands Cancer Institute in Amsterdam (The Netherlands), finally gaining his Ph.D. in 2013 with cum laude qualification. After a postdoctoral position at King’s College of London (UK), he returned to Spain where currently he is a postdoctoral researcher in virology at INIA–CSIC and professor at Universidad Complutense de Madrid and Universidad Francisco de Vitoria. He is a member of the Spanish Society of Virology and BICS group, which focuses on the development and applications of new chemicals and drugs as antivirals for global health.
Miguel Ángel Cuesta-Geijo received his M.Sc. in Microbiology and obtained his Ph.D. in Virology in 2013 from the Autónoma University of Madrid (Spain). He began his Ph.D. in 2008, studying the involvement of the endocitic pathway in African Swine Fever Virus infection. In 2011, he was awarded an international fellowship as part of his Ph.D. student training in the Cell Biology Division at The Netherlands Cancer Institute in Amsterdam (The Netherlands), finally gaining his Ph.D. in 2013 with cum laude qualification. After a postdoctoral position at King’s College of London (UK), he returned to Spain where currently he is a postdoctoral researcher in virology at INIA–CSIC and professor at Universidad Complutense de Madrid and Universidad Francisco de Vitoria. He is a member of the Spanish Society of Virology and BICS group, which focuses on the development and applications of new chemicals and drugs as antivirals for global health.